cycloleucine has been researched along with melphalan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Altman, SJ; Aust, JB; Cruz, AB; Fletcher, WS; Frelick, RW; Hill, GJ; Metter, G; Ramirez, G; Thames, EA | 1 |
| BERGSAGEL, DE | 1 |
1 trial(s) available for cycloleucine and melphalan
| Article | Year |
|---|---|
Combination chemotherapy for soft-tissue sarcomas: a phase III study.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cycloleucine; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Melphalan; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1979 |
2 other study(ies) available for cycloleucine and melphalan
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell- and Tissue-Based Therapy; Cycloleucine; Cycloparaffins; Melphalan; Mitomycin; Multiple Myeloma; Plasma; Plasma Cells | 1962 |